These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 19013334

  • 1. Emerging importance of infections due to zygomycetes in organ transplant recipients.
    Sun HY, Singh N.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S115-8. PubMed ID: 19013334
    [Abstract] [Full Text] [Related]

  • 2. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.
    Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Flörl C, Johnson L, Dubberke ER, Barron MA, Lortholary O.
    J Infect Dis; 2009 Sep 15; 200(6):1002-11. PubMed ID: 19659439
    [Abstract] [Full Text] [Related]

  • 3. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N.
    Clin Infect Dis; 2004 Oct 15; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [Abstract] [Full Text] [Related]

  • 4. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients.
    Stelzmueller I, Lass-Floerl C, Geltner C, Graziadei I, Schneeberger S, Antretter H, Mueller L, Zelger B, Singh N, Pruett TL, Margreiter R, Bonatti H.
    Transpl Int; 2008 Jun 15; 21(6):534-46. PubMed ID: 18363572
    [Abstract] [Full Text] [Related]

  • 5. Changing epidemiology of an emerging infection: zygomycosis.
    Meis JF, Chakrabarti A.
    Clin Microbiol Infect; 2009 Oct 15; 15 Suppl 5():10-4. PubMed ID: 19754750
    [Abstract] [Full Text] [Related]

  • 6. Incidence of zygomycosis in transplant recipients.
    Cuenca-Estrella M, Bernal-Martinez L, Isla G, Gomez-Lopez A, Alcazar-Fuoli L, Buitrago MJ.
    Clin Microbiol Infect; 2009 Oct 15; 15 Suppl 5():37-40. PubMed ID: 19754755
    [Abstract] [Full Text] [Related]

  • 7. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
    Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA.
    Clin Infect Dis; 2004 Aug 15; 39(4):584-7. PubMed ID: 15356827
    [Abstract] [Full Text] [Related]

  • 8. Invasive zygomycosis in transplant recipients.
    Uçkay I, Chalandon Y, Sartoretti P, Rohner P, Berney T, Hadaya K, van Delden C.
    Clin Transplant; 2007 Aug 15; 21(4):577-82. PubMed ID: 17645724
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary zygomycosis.
    Pyrgos V, Shoham S, Walsh TJ.
    Semin Respir Crit Care Med; 2008 Apr 15; 29(2):111-20. PubMed ID: 18365993
    [Abstract] [Full Text] [Related]

  • 10. [Zygomycetes and zygomycosis in the new era of antifungal therapies].
    Torres-Narbona M, Guinea J, Muñoz P, Bouza E.
    Rev Esp Quimioter; 2007 Dec 15; 20(4):375-86. PubMed ID: 18563211
    [Abstract] [Full Text] [Related]

  • 11. Zygomycosis--current epidemiological aspects.
    Glöckner A, Vehreschild JJ, Cornely OA.
    Mycoses; 2007 Dec 15; 50 Suppl 1():50-5. PubMed ID: 17394610
    [Abstract] [Full Text] [Related]

  • 12. Breakthrough zygomycosis and voriconazole.
    Pagano L, Gleissner B, Fianchi L.
    J Infect Dis; 2005 Oct 15; 192(8):1496-7; author reply 1497. PubMed ID: 16170771
    [No Abstract] [Full Text] [Related]

  • 13. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP.
    J Infect Dis; 2009 May 01; 199(9):1399-406. PubMed ID: 19358672
    [Abstract] [Full Text] [Related]

  • 14. Cutaneous zygomycosis.
    Skiada A, Petrikkos G.
    Clin Microbiol Infect; 2009 Oct 01; 15 Suppl 5():41-5. PubMed ID: 19754756
    [Abstract] [Full Text] [Related]

  • 15. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.
    Kontoyiannis DP, Lewis RE.
    Infect Dis Clin North Am; 2006 Sep 01; 20(3):581-607, vi. PubMed ID: 16984870
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of invasive zygomycosis infections in renal transplant recipients.
    Forrest GN, Mankes K.
    Transpl Infect Dis; 2007 Jun 01; 9(2):161-4. PubMed ID: 17462005
    [Abstract] [Full Text] [Related]

  • 17. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
    Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II.
    J Infect Dis; 2005 Apr 15; 191(8):1350-60. PubMed ID: 15776383
    [Abstract] [Full Text] [Related]

  • 18. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Salavert M, Jarque I.
    Rev Esp Quimioter; 2006 Mar 15; 19(1):11-3. PubMed ID: 16688286
    [No Abstract] [Full Text] [Related]

  • 19. Changing epidemiology of systemic fungal infections.
    Richardson M, Lass-Flörl C.
    Clin Microbiol Infect; 2008 May 15; 14 Suppl 4():5-24. PubMed ID: 18430126
    [Abstract] [Full Text] [Related]

  • 20. Clinical presentation of zygomycosis.
    Mantadakis E, Samonis G.
    Clin Microbiol Infect; 2009 Oct 15; 15 Suppl 5():15-20. PubMed ID: 19754751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.